These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16776648)

  • 1. Optimization of the conjugation method for a serogroup B/C meningococcal vaccine.
    Fukasawa LO; Schenkman RP; Perciani CT; Carneiro SM; Dias WO; Tanizaki MM
    Biotechnol Appl Biochem; 2006 Nov; 45(Pt 3):141-6. PubMed ID: 16776648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of conjugation methodology on the immunogenicity and protective efficacy of meningococcal group C polysaccharide-P64k protein conjugates.
    Carmenate T; Canaán L; Alvarez A; Delgado M; González S; Menéndez T; Rodés L; Guillén G
    FEMS Immunol Med Microbiol; 2004 Apr; 40(3):193-9. PubMed ID: 15039094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant can improve protection induced by OMV vaccine against Neisseria meningitidis serogroups B/C in neonatal mice.
    Fukasawa LO; Dias WO; Schenkman RP; Raw I; Tanizaki MM
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):205-10. PubMed ID: 15196569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningococcal vaccines.
    Danzig L
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S285-92. PubMed ID: 15597071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic correlates of protection for evaluating the response to meningococcal vaccines.
    Balmer P; Borrow R
    Expert Rev Vaccines; 2004 Feb; 3(1):77-87. PubMed ID: 14761245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neisseria meningitidis serogroup C polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent meningococcus vaccine candidate.
    Fukasawa LO; Gorla MC; Schenkman RP; Garcia LR; Carneiro SM; Raw I; Tanizaki MM
    Vaccine; 1999 Aug; 17(23-24):2951-8. PubMed ID: 10462229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
    Rosenqvist E; Høiby EA; Bjune G; Aase A; Halstensen A; Lehmann AK; Paulssen J; Holst J; Michaelsen TE; Nøkleby H; Frøholm LO; Closs O
    Dev Biol Stand; 1998; 92():323-33. PubMed ID: 9554288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New meningococcal C polysaccharide-tetanus toxoid conjugate Physico-chemical and immunological characterization.
    Cuello M; Cabrera O; Martinez I; Del Campo JM; Camaraza MA; Sotolongo F; Pérez O; Sierra G
    Vaccine; 2007 Feb; 25(10):1798-805. PubMed ID: 17240485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
    Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of vaccine research and development: meningococcal disease.
    Girard MP; Preziosi MP; Aguado MT; Kieny MP
    Vaccine; 2006 May; 24(22):4692-700. PubMed ID: 16621189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine.
    Chandramohan D; Hodgson A; Coleman P; Baiden R; Asante K; Awine E; Owusu-Agyei S; Boutriau D; Nelson CB; Greenwood B
    Vaccine; 2007 Sep; 25 Suppl 1():A83-91. PubMed ID: 17521782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
    Perrett KP; Snape MD; Ford KJ; John TM; Yu LM; Langley JM; McNeil S; Dull PM; Ceddia F; Anemona A; Halperin SA; Dobson S; Pollard AJ
    Pediatr Infect Dis J; 2009 Mar; 28(3):186-93. PubMed ID: 19209097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quadrivalent meningococcal conjugate vaccines.
    Pace D; Pollard AJ; Messonier NE
    Vaccine; 2009 Jun; 27 Suppl 2():B30-41. PubMed ID: 19477560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
    Gudlavalleti SK; Lee CH; Norris SE; Paul-Satyaseela M; Vann WF; Frasch CE
    Vaccine; 2007 Nov; 25(46):7972-80. PubMed ID: 17936445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of serogroups in multivalent polysaccharide-based meningococcal vaccines: optimisation of hydrolysis conditions and chromatographic methods.
    Cook MC; Bliu A; Kunkel JP
    Vaccine; 2013 Aug; 31(36):3702-11. PubMed ID: 23764533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity and cross-reactivity of antibodies induced in mice by immunization with a group B meningococcal conjugate.
    Coquillat D; Bruge J; Danve B; Latour M; Hurpin C; Schulz D; Durbec P; Rougon G
    Infect Immun; 2001 Nov; 69(11):7130-9. PubMed ID: 11598089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control and lot release of meningococcal group C conjugate vaccines.
    Suker J; Feavers IM; Corbel MJ; Jones C; Bolgiano B
    Expert Rev Vaccines; 2004 Oct; 3(5):533-40. PubMed ID: 15485333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three ELISA protocols to measure antibody responses elicited against serogroup C meningococcal polysaccharide in mouse, monkey and human sera.
    Guirola M; Carmenate T; Menéndez T; Alvarez A; González S; Guillén G
    J Microbiol Methods; 2006 Apr; 65(1):135-43. PubMed ID: 16122825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of impact of temperature and pH alterations on the size and antigenicity of meningococcal serogroup A and X polysaccharides and conjugates.
    Sharma N; Hanif S; Rana R; Upadhyay D; Chhikara MK
    Vaccine; 2019 Feb; 37(7):965-972. PubMed ID: 30651197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming the need for a cold chain with conjugated meningococcal Group C vaccine: A controlled, randomized, double-blind study in toddlers on the safety and immunogenicity of Menjugate, stored at room temperature for 6 months.
    Schöndorf I; Banzhoff A; Nicolay U; Diaz-Mitoma F
    Vaccine; 2007 Jan; 25(7):1175-82. PubMed ID: 17095129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.